(Q46852567)

25 December 2017

title

Immune response induced by Salmonella typhimurium defective in ppGpp synthesis (English)

1 reference

25 December 2017

main subject

Salmonella Typhimurium

object named as

Salmonella typhimurium

1 reference

Hee Sam Na

1

1 reference

25 December 2017

Hyun Ju Kim

2

1 reference

25 December 2017

Hyun-Chul Lee

3

1 reference

25 December 2017

Yeongjin Hong

4

1 reference

25 December 2017

Joon Haeng Rhee

5

1 reference

25 December 2017

Hyon E Choy

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

25 December 2017

published in

Vaccine

1 reference

25 December 2017

volume

24

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

2027-2034

1 reference

25 December 2017

Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Mucosal immunity: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Live oral avirulent Salmonella vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The route of enteric infection in normal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Salmonella pathogenicity islands: big virulence in small packages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

DksA: a critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Regulation through the Secondary Channel—Structural Framework for ppGpp-DksA Synergism during Transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The putative invasion protein chaperone SicA acts together with InvF to activate the expression of Salmonella typhimurium virulence genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Type III secretion chaperone-dependent regulation: activation of virulence genes by SicA and InvF in Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Control of RNA synthesis in Escherichia coli. I. Amino acid dependence of the synthesis of the substrates of RNA polymerase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

A genetic locus for the regulation of ribonucleic acid synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Non-invasive Salmonella typhimurium mutants are avirulent because of an inability to enter and destroy M cells of ileal Peyer's patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Salmonella SirA is a global regulator of genes mediating enteropathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Back to log phase: sigma S as a global regulator in the osmotic control of gene expression in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Salmonella stress management and its relevance to behaviour during intestinal colonisation and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Molecular analysis of spv virulence genes of the salmonella virulence plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The alternative sigma factor katF (rpoS) regulates Salmonella virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Synthesis of the stationary-phase sigma factor sigma s is positively regulated by ppGpp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

RpoS-dependent promoters require guanosine tetraphosphate for induction even in the presence of high levels of sigma(s)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Origin and differentiation of lymphocytes involved in the secretory IgA responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of Salmonella typhimurium rpoS and rpoS-dependent genes in the intracellular environment of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.11.031

1 reference

25 December 2017

1 reference

25 December 2017